These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24493389)

  • 1. Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
    El-Galaly TC; Mylam KJ; Bøgsted M; Brown P; Rossing M; Gang AO; Haglund A; Arboe B; Clausen MR; Jensen P; Pedersen M; Bukh A; Jensen BA; Poulsen CB; d'Amore F; Hutchings M
    Am J Hematol; 2014 Jun; 89(6):575-80. PubMed ID: 24493389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission.
    Truong Q; Shah N; Knestrick M; Curley B; Hu Y; Craig M; Hamadani M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):50-5. PubMed ID: 24119465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.
    Picardi M; Pugliese N; Cirillo M; Zeppa P; Cozzolino I; Ciancia G; Pettinato G; Salvatore C; Quintarelli C; Pane F
    Radiology; 2014 Jul; 272(1):262-74. PubMed ID: 24708193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.
    Goldschmidt N; Or O; Klein M; Savitsky B; Paltiel O
    Ann Hematol; 2011 Feb; 90(2):165-71. PubMed ID: 20706721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
    Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
    Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation surveillance strategies for patients with lymphoma.
    Cohen JB; Kurtz DM; Staton AD; Flowers CR
    Future Oncol; 2015; 11(13):1977-91. PubMed ID: 26161931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission.
    Pingali SR; Jewell SW; Havlat L; Bast MA; Thompson JR; Eastwood DC; Bartlett NL; Armitage JO; Wagner-Johnston ND; Vose JM; Fenske TS
    Cancer; 2014 Jul; 120(14):2122-9. PubMed ID: 24711253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass.
    Dann EJ; Berkahn L; Mashiach T; Frumer M; Agur A; McDiarmid B; Bar-Shalom R; Paltiel O; Goldschmidt N
    Br J Haematol; 2014 Mar; 164(5):694-700. PubMed ID: 24313286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas.
    Lin TL; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Tang TC; Chang H; Hung YS; Lu SC
    Ann Hematol; 2012 Nov; 91(11):1741-5. PubMed ID: 22729139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.
    El-Galaly TC; Mylam KJ; Brown P; Specht L; Christiansen I; Munksgaard L; Johnsen HE; Loft A; Bukh A; Iyer V; Nielsen AL; Hutchings M
    Haematologica; 2012 Jun; 97(6):931-6. PubMed ID: 22207683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation.
    Kapke JT; Epperla N; Shah N; Richardson K; Carrum G; Hari PN; Pingali SR; Hamadani M; Karmali R; Fenske TS
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):408-414. PubMed ID: 28756899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
    Becherer A; Mitterbauer M; Jaeger U; Kalhs P; Greinix HT; Karanikas G; Pötzi C; Raderer M; Dudczak R; Kletter K
    Leukemia; 2002 Feb; 16(2):260-7. PubMed ID: 11840293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population.
    Liedtke M; Hamlin PA; Moskowitz CH; Zelenetz AD
    Ann Oncol; 2006 Jun; 17(6):909-13. PubMed ID: 16672295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group.
    Voss SD; Chen L; Constine LS; Chauvenet A; Fitzgerald TJ; Kaste SC; Slovis T; Schwartz CL
    J Clin Oncol; 2012 Jul; 30(21):2635-40. PubMed ID: 22689804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy.
    Friedmann AM; Wolfson JA; Hudson MM; Weinstein HJ; Link MP; Billett A; Larsen EC; Yock T; Donaldson SS; Marcus K; Krasin MJ; Howard SC; Metzger ML
    Pediatr Blood Cancer; 2013 Sep; 60(9):1458-63. PubMed ID: 23677874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal disease surveillance strategies in non-Hodgkin lymphoma.
    Cohen JB; Flowers CR
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):481-7. PubMed ID: 25696898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma.
    Cohen JB; Behera M; Thompson CA; Flowers CR
    Blood; 2017 Feb; 129(5):561-564. PubMed ID: 27956385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Routine Surveillance Laboratory Testing in Detecting Relapse in Patients With Classic Hodgkin Lymphoma in First Remission: Results From a Large Single-Institution Study.
    Lynch RC; Sundaram V; Desai M; Henry S; Wood D; Daadi S; Hoppe RT; Advani R
    JCO Oncol Pract; 2020 Sep; 16(9):e902-e911. PubMed ID: 32369413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of prognostic factors in children with B-cell non-Hodgkin lymphoma (B-NHL)].
    Zajac-Spychała O; Derwich K; Mańkowska M; Konatkowska B; Mańkowski P; Wachowiak J
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1087-91. PubMed ID: 19531831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.